MARKET

ANIK

ANIK

Anika
NASDAQ

Real-time Quotes | Nasdaq Last Sale

53.50
-0.75
-1.38%
Closed 16:41 12/12 EST
OPEN
54.18
PREV CLOSE
54.25
HIGH
54.98
LOW
53.31
VOLUME
93.08K
TURNOVER
--
52 WEEK HIGH
75.72
52 WEEK LOW
29.01
MARKET CAP
763.41M
P/E (TTM)
24.72
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ANIK and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ANIK News

  • ProQR (PRQR) Begins Dosing in Phase I/II Eye Disorder Study
  • Zacks.12h ago
  • BioCryst Submits NDA for Hereditary Angioedema Candidate
  • Zacks.13h ago
  • Amgen's Osteoporosis Drug Evenity Gets Approval in Europe
  • Zacks.18h ago
  • Is Anika Therapeutics, Inc. (ANIK) A Good Stock To Buy ?
  • Insider Monkey.1d ago

More

Industry

Pharmaceuticals
+0.77%
Pharmaceuticals & Medical Research
+0.73%

Hot Stocks

Name
Price
%Change

About ANIK

Anika Therapeutics, Inc. is an orthopedic medicines company. The Company is engaged in developing, manufacturing and commercializing products based on its hyaluronic acid (HA) technology. The Company's orthopedic medicine portfolio includes ORTHOVISC, MONOVISC, and CINGAL, which alleviate pain and restore joint function by replenishing depleted HA, and HYALOFAST, a solid HA-based scaffold to aid cartilage repair and regeneration. The Company's therapeutic offerings consist of products in the areas, including Orthobiologics, which includes viscosupplementation and regenerative orthopedic products; Dermal, which includes wound care products; Surgical, which includes products used to prevent post-surgical adhesions, and Other, which includes the Company's ophthalmic and veterinary products. The Company also offers products made from HA based on two other technologies: HYAFF, which is a solid form of HA, and ACP gel, an autocross-linked polymer of HA.
More

Webull offers Anika Therapeutics Inc (ANIK) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.